Global point‑of‑care testing market to hit $64.8b by 2031

This will be driven by increasing demand for quick testing.

The global point-of-care testing (POCT) market is projected to reach $64.8b by 2031, registering a compound annual growth rate of 7.5%, according to a Wissen Research report.

The report attributes the growth to increasing demand for quick testing, decentralisation of healthcare, and early disease diagnosis.

However, ensuring laboratory-level accuracy in decentralised testing environments, and sample handling and operator training variability, remains a major market challenge.

The North America region commands a prominent market share on account of elevated health infrastructure, rapid diagnostics adoption, and increasing demands for decentralised testing from the United States and Canada.

Meanwhile, the Asia Pacific is anticipated to witness a high CAGR due to increased healthcare access, prevalence of chronic diseases, and investment in diagnostic infrastructure in countries like China, India, and Japan.

The report noted that the region provides opportunities for POCT suppliers on account of growing needs for portable and affordable testing solutions.